Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases

Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases

US Patent 6096722 · Granted Aug 1, 2000

Estimated economic value: $7,167,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides directed to huntingtin2025
Selective reduction of allelic variants2024
Compositions for modulating Ataxin 2 expression2023
Methods for treating Alzheimer's disease2023
Compositions and methods for modulation of SMN2 splicing in a subject2022
Compositions and methods for modulation of protein aggregation2022
Modulation of Huntington expression2022
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof2022
Antisense compounds and uses thereof2022
Combinations for the modulation of SMN expression2021
Methods for modulating expression of C9ORF72 antisense transcript2021
Compositions comprising alternating 2′-modified nucleosides for use in gene modu2021